VitaNova Life Sciences Statistics
VitaNova Life Sciences (VNOV) Stock Statistics & Valuation Metrics
Total Valuation
VitaNova Life Sciences has a market cap or net worth of $23.51M. The enterprise value is $39.00T.
- Market Cap
- $23.51M
- Enterprise Value
- $39.00T
Share Statistics
VitaNova Life Sciences has 8,337,454 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,337,454
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
VitaNova Life Sciences’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is 44.72%.
- Return on Equity (ROE)
- 0.45
- Return on Assets (ROA)
- 0.38
- Return on Invested Capital (ROIC)
- 44.72%
- Return on Capital Employed (ROCE)
- 0.63
- Revenue Per Employee
- 380.30K
- Profits Per Employee
- 121.54K
- Employee Count
- 7
- Asset Turnover
- 1.18
- Inventory Turnover
- 24.55
Valuation Ratios
The current PE Ratio of VitaNova Life Sciences is 46.67. VitaNova Life Sciences’s PEG ratio is -7.76.
- PE Ratio
- 46.67
- PS Ratio
- 14.42
- PB Ratio
- 21.21
- Price to FCF
- 34.58
- Price to Operating Cash Flow
- 34.58
- PEG Ratio
- -7.76
Income Statement
In the last 12 months, VitaNova Life Sciences had revenue of 2.66M and earned 850.75K in profits. Earnings per share was 0.10.
- Revenue
- 2.66M
- Gross Profit
- 1.58M
- Operating Income
- 1.21M
- Pretax Income
- 1.20M
- Net Income
- 850.75K
- EBITDA
- 1.21M
- Earnings Per Share (EPS)
- 0.10
Cash Flow
In the last 12 months, operating cash flow was 1.16M and capital expenditures 0, giving a free cash flow of 1.16M billion.
- Operating Cash Flow
- 1.16M
- Free Cash Flow
- 1.16M
- Free Cash Flow per Share
- 0.14
Dividends & Yields
VitaNova Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.89%
- Earnings Yield
- 2.14%
Stock Price Statistics
- Beta
- -5.65
- 52-Week Price Change
- -41.61%
- 50-Day Moving Average
- 2.83
- 200-Day Moving Average
- 2.81
- Relative Strength Index (RSI)
- 48.27
- Average Volume (3m)
- 280
Financial Position
VitaNova Life Sciences as a current ratio of 6.49, with Debt / Equity ratio of 0.00%
- Current Ratio
- 6.49
- Quick Ratio
- 6.36
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.65
- Interest Coverage Ratio
- 268.16
Taxes
In the past 12 months, VitaNova Life Sciences has paid 353.56K in taxes.
- Income Tax
- 353.56K
- Effective Tax Rate
- 0.29
Enterprise Valuation
VitaNova Life Sciences EV to EBITDA ratio is 31.00, with an EV/FCF ratio of 33.49.
- EV to Sales
- 13.97
- EV to EBITDA
- 31.00
- EV to Free Cash Flow
- 33.49
- EV to Operating Cash Flow
- 33.49
Balance Sheet
VitaNova Life Sciences has $1.26M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.26M billion.
- Cash & Marketable Securities
- $1.26M
- Total Debt
- $0.00
- Net Cash
- $1.26M
- Net Cash Per Share
- $0.15
- Tangible Book Value Per Share
- $0.08
Margins
Gross margin is 60.03%, with operating margin of 46.29%, and net profit margin of 30.90%.
- Gross Margin
- 60.03%
- Operating Margin
- 46.29%
- Pretax Margin
- 44.97%
- Net Profit Margin
- 30.90%
- EBITDA Margin
- 45.06%
- EBIT Margin
- 45.06%
Analyst Forecast
The average price target for VitaNova Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 22.04%
- EPS Growth Forecast
- -113.29%

